Amarin Corporation plc

1.92-0.0700-3.52%Vol 2.67M1Y Perf -57.66%
Jun 24th, 2022 16:00 DELAYED
BID1.90 ASK1.93
Open2.01 Previous Close1.99
Pre-Market- After-Market1.92
 - -  - -%
Target Price
3.57 
Analyst Rating
Hold 3.00
Potential %
85.94 
Finscreener Ranking
★★★★+     55.78
Insiders Trans % 3/6/12 mo.
100/100/100 
Value Ranking
★★★★+     58.83
Insiders Value % 3/6/12 mo.
100/100/100 
Growth Ranking
★★★★     56.60
Insiders Shares Cnt. % 3/6/12 mo.
100/100/100 
Income Ranking
 —    -
Price Range Ratio 52W %
16.67 
Earnings Rating
Buy
Market Cap762.26M 
Earnings Date
4th Aug 2022
Alpha0.04 Standard Deviation0.59
Beta2.12 

Today's Price Range

1.902.01

52W Range

1.115.97

5 Year PE Ratio Range

-51.90-10.90

Summary:

Neutral

Technical Indicators: Buy
Moving Averages: Sell
Performance
1 Week
4.92%
1 Month
41.18%
3 Months
-41.46%
6 Months
-45.30%
1 Year
-57.66%
3 Years
-89.43%
5 Years
-42.86%
10 Years
-85.66%

TickerPriceChg.Chg.%
AMRN1.92-0.0700-3.52
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Financial StrengthValueIndustryS&P 500US Markets
1.60
2.60
0.02
0.02
-213.10
Leverage Ratio 1.60
ProfitabilityValueIndustryS&P 500US Markets
78.50
-2.90
-2.30
-15.50
-4.15
RevenueValueIndustryS&P 500US Markets
535.65M
1.35
37.61
43.15
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.02-0.08-300.00
Q04 2021-0.010.04500.00
Q03 2021-0.030.01133.33
Q02 2021-0.040.02150.00
Q01 2021-0.050.00100.00
Q04 2020-0.010.01200.00
Q03 20200.01-0.02-300.00
Q02 2020-0.080.01112.50
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.05--
9/2022 QR-0.02--
12/2022 FY-0.16--
12/2023 FY-0.12-1 300.00Negative
Next Report Date4th Aug 2022
Estimated EPS Next Report-0.05
Estimates Count5
EPS Growth Next 5 Years %-
Volume Overview
Volume2.67M
Shares Outstanding397.01K
Shares Float388.84M
Trades Count10.77K
Dollar Volume5.18M
Avg. Volume4.03M
Avg. Weekly Volume3.22M
Avg. Monthly Volume4.41M
Avg. Quarterly Volume4.45M

Amarin Corporation plc (NASDAQ: AMRN) stock closed at 1.92 per share at the end of the most recent trading day (a -3.52% change compared to the prior day closing price) with a volume of 2.67M shares and market capitalization of 762.26M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 1000 people. Amarin Corporation plc CEO is John F. Thero.

The one-year performance of Amarin Corporation plc stock is -57.66%, while year-to-date (YTD) performance is -43.03%. AMRN stock has a five-year performance of -42.86%. Its 52-week range is between 1.11 and 5.97, which gives AMRN stock a 52-week price range ratio of 16.67%

Amarin Corporation plc currently has a PE ratio of -36.60, a price-to-book (PB) ratio of 1.13, a price-to-sale (PS) ratio of 1.36, a price to cashflow ratio of 329.80, a PEG ratio of 2.32, a ROA of -2.26%, a ROC of -3.52% and a ROE of -3.48%. The company’s profit margin is -4.15%, its EBITDA margin is -2.30%, and its revenue ttm is $535.65 Million , which makes it $1.35 revenue per share.

Of the last four earnings reports from Amarin Corporation plc, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.05 for the next earnings report. Amarin Corporation plc’s next earnings report date is 04th Aug 2022.

The consensus rating of Wall Street analysts for Amarin Corporation plc is Hold (3), with a target price of $3.57, which is +85.94% compared to the current price. The earnings rating for Amarin Corporation plc stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Amarin Corporation plc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Amarin Corporation plc has a Neutral technical analysis rating based on Technical Indicators (ADX : 21.04, ATR14 : 0.15, CCI20 : 107.03, Chaikin Money Flow : 0.09, MACD : 0.02, Money Flow Index : 62.05, ROC : 6.08, RSI : 55.20, STOCH (14,3) : 74.42, STOCH RSI : 0.69, UO : 55.58, Williams %R : -25.58), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Amarin Corporation plc in the last 12-months were: Aaron D. Berg (Option Excercise at a value of $0), John F. Thero (Option Excercise at a value of $0), Joseph S. Zakrzewski (Buy at a value of $38 999), Joseph T. Kennedy (Option Excercise at a value of $0), Karim Mikhail (Option Excercise at a value of $0), Michael Wayne Kalb (Option Excercise at a value of $0), Per Wold-Olsen (Buy at a value of $92 730), Steven B. Ketchum (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (25.00 %)
2 (28.57 %)
6 (75.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
4 (50.00 %)
4 (57.14 %)
2 (25.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
2 (25.00 %)
1 (14.29 %)
0 (0.00 %)
Summary RatingHold
3.00
Hold
2.71
Strong Buy
1.50

Amarin Corporation plc

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular health. Its lead product includes Vascepa.

CEO: John F. Thero

Telephone: +353 16699020

Address: 77 Sir John Rogerson's Quay, Dublin D02 VK60, , IE

Number of employees: 1 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

83%17%

Bearish Bullish

65%35%

Bearish Bullish

56%44%

News

Stocktwits